On the use of propensity scores in case of rare exposure
File(s)art%3A10.1186%2Fs12874-016-0135-1.pdf (2.54 MB)
Published version
Author(s)
Hajage, D
Tubach, F
Steg, PG
Bhatt, DL
De Rycke, Y
Type
Journal Article
Abstract
Background
Observational post-marketing assessment studies often involve evaluating the effect of a rare treatment on a time-to-event outcome, through the estimation of a marginal hazard ratio. Propensity score (PS) methods are the most used methods to estimate marginal effect of an exposure in observational studies. However there is paucity of data concerning their performance in a context of low prevalence of exposure.
Methods
We conducted an extensive series of Monte Carlo simulations to examine the performance of the two preferred PS methods, known as PS-matching and PS-weighting to estimate marginal hazard ratios, through various scenarios.
Results
We found that both PS-weighting and PS-matching could be biased when estimating the marginal effect of rare exposure. The less biased results were obtained with estimators of average treatment effect in the treated population (ATT), in comparison with estimators of average treatment effect in the overall population (ATE). Among ATT estimators, PS-weighting using ATT weights outperformed PS-matching. These results are illustrated using a real observational study.
Conclusions
When clinical objectives are focused on the treated population, applied researchers are encouraged to estimate ATT with PS-weighting for studying the relative effect of a rare treatment on time-to-event outcomes.
Observational post-marketing assessment studies often involve evaluating the effect of a rare treatment on a time-to-event outcome, through the estimation of a marginal hazard ratio. Propensity score (PS) methods are the most used methods to estimate marginal effect of an exposure in observational studies. However there is paucity of data concerning their performance in a context of low prevalence of exposure.
Methods
We conducted an extensive series of Monte Carlo simulations to examine the performance of the two preferred PS methods, known as PS-matching and PS-weighting to estimate marginal hazard ratios, through various scenarios.
Results
We found that both PS-weighting and PS-matching could be biased when estimating the marginal effect of rare exposure. The less biased results were obtained with estimators of average treatment effect in the treated population (ATT), in comparison with estimators of average treatment effect in the overall population (ATE). Among ATT estimators, PS-weighting using ATT weights outperformed PS-matching. These results are illustrated using a real observational study.
Conclusions
When clinical objectives are focused on the treated population, applied researchers are encouraged to estimate ATT with PS-weighting for studying the relative effect of a rare treatment on time-to-event outcomes.
Date Issued
2016-03-31
Date Acceptance
2016-03-15
Citation
BMC Medical Research Methodology, 2016, 16
ISSN
1471-2288
Publisher
BioMed Central
Journal / Book Title
BMC Medical Research Methodology
Volume
16
Copyright Statement
© Hajage et al. 2016. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
License URL
Subjects
Science & Technology
Life Sciences & Biomedicine
Health Care Sciences & Services
Propensity scores
Observational studies
Pharmacoepidemiology
Rare exposure
Hazard ratio
Monte Carlo simulations
MARGINAL STRUCTURAL MODELS
CARDIOVASCULAR EVENT RATES
ESTIMATING RELATIVE RISKS
LOGISTIC-REGRESSION
RANDOMIZED EXPERIMENTS
MONTE-CARLO
PERFORMANCE
OUTCOMES
ATHEROTHROMBOSIS
OUTPATIENTS
General & Internal Medicine
1117 Public Health And Health Services
Publication Status
Published
Article Number
38